简介:目的:在高度轴性近视眼与正常眼轴眼之间作对比分析,观察眼轴长度与白内障超声乳化加人工晶状体(intraocularlens,IOL)植入手术风险的相关性。方法:回顾性分析2012-02/2013-02在我院行白内障超声乳化加IOL植入术的连续病例843例1042眼。正常眼轴组(21~24mm)853眼,高度轴性近视组(≥26mm)189眼。对比分析两组的眼内并发症,包括玻璃体脱失,后囊膜破裂,晶状体核掉入玻璃体腔和IOL位置异常。结果:年龄在两个组中都是眼内并发症的风险因素,年龄的增长与眼内并发症的发生呈正相关,眼轴长度与眼内并发症的发生呈正相关,尤其对于后囊膜破裂和玻璃体脱失两个并发症。结论:此项研究结果提示,年龄和眼轴长度是白内障超声乳化手术并发症发生的两个风险因素,了解这些风险并提前做好准备可能会降低并发症的发生。
简介:目的分析应用小切口非超声乳化手术治疗高度近视白内障患者的术后最佳矫正视力与患眼眼轴长度的相关。方法以本院眼科2011年1月-2015年1月期间收治经筛选后的116眼高度近视白内障为研究对象,按照眼轴长度分为2个对照组,统计各组术后最佳矫正视力,取其平均值作为对比。结果眼轴长度≥26mm、〈29mm组50例(79眼),术后3个月平均最佳矫正视力0.58±0.07;眼轴长度≥29mm组32例(37眼),术后3个月平均最佳矫正视力0.15±0.06。比较两组术后3个月平均最佳矫正视力,通过统计处理,t=4.05,P〈0.05,两组之间有非常显著差别。说明高度近视白内障眼白内障摘除术后最佳矫正视力随眼轴长度增长而相应下降。结论高度近视白内障眼术后最佳矫正视力与其眼轴长度成负相关性。
简介:Endogenousaspergillusendophthalmitis(EAE)afterkidneytransplantisararebutimportantclinicalproblemduetopotentiallydevastatingconsequences.EarlydiagnosisofEAE,timelyremovalofaffectedvitreousbyvitrectomy,properanti-fungaltreatment,allcontributedtothesuccessfulcontrolofthedisease.TherapeuticsuccessofEAEinpost-transplantpatientsdependslargelyonpromptdiagnosis.DefinitediagnosisofEAEisbasedonpositivecultureresultsofvitreousspecimen,whilefundoscopyandBscanultrasoundmayaidearlydiagnosis.Intermsofanti-fungalmedicine,amphotericinBhaslongbeenthefirstchoice,butitssystemicapplicaitonhassevereadversereactions,especiallyforpatientswithimpairedrenalfunction.Herein,wereportthetreatmentmodalityofEAEafterkidneytransplantwithvitrectomy,systemicadministrationofmicafunginplusvoriconazole,topicalapplicationoffluconazolandamphotercinB.
简介:目的分析剥脱综合征(ES)患者和正常人眼轴及中央前房深度与眼压的相关性。方法2010年1月~2012年1月间来本院就诊的Es患者106例(106眼)、正常人69例(69眼),均为维吾尔族。观察Es眼和非ES眼眼轴长度、中央前房深度及眼压有无差异,分析眼轴及中央前房深度与眼压的相关性。结果ES患者眼轴长度为(22.89±0.91)mm,正常人眼轴长度为(23.12±0.97)mm,差异无统计学意义(P=0.12);ES患者前房深度为(2.84±0.41)mm,正常人前房深度为(2.93±0.39)mm,差异无统计学意义(P=0.14);ES患者眼压为(26.72±15.70)mmHg(1mmHg=0.133kPa),正常人眼压为(14.39±2.19)mmHg,差异有统计学意义(P=0.00)。Es患者眼轴与眼压具有相关性(r=-0.412,P=0.00);正常人眼轴与眼压不具有相关性(r=-0.102,P=0.405)。ES患者中央前房深度与眼压具有相关性(r=-0.33,P=0.001);正常人中央前房深度与眼压不具有相关性(r=-0.102,P=0.406)。结论维吾尔族ES患者的眼压较正常人高,其眼轴及中央前房深度与眼压具有负相关性。(中国眼耳鼻喉科杂志,2013,13:170—172)
简介:AIM:Tocharacterizetheclinicalfeatures,diagnosis,treatmentandprognosisofuveitisassociatedwithankylosingspondylitis(AS)inChinesepatients.·METHODS:TwohundredandthreepatientswithuveitisassociatedwithASfollowed-upintheThirdMilitaryMedicalUniversityDapingHospitalbetween2005and2010wereretrospectivelyevaluatedinthisstudy.Completeophthalmologicalexaminationswereevaluatedatbaselineandduringthefollow-upperiod.Thegender,age,follow-uptime,meanfrequencyofuveitisonset,andaccompanyingeyeexaminationfindings,history,demographicalparameterswerereviewed.Allthepatientspresentedcompleteclinicalandradiologic(sacroiliac,lumbar,dorsalandcervicalspine,knee,ankle,shoulder,hip,elbow)evaluation.HLA-B27typingwasalsosearched.·RESULTS:Therewere203patientsdiagnosedwithASassociateduveitis.AllshowedsacroiliacX-raychangesindicativeofAS.Therewere184maleand19femalepatients.Theaverageageofpatientswas35±12(range18-50).Meanfollow-upperiodwas2.4years(1-5years).Acuteanterioruveitiswasthemostcommontypeofuveitisinbothgenders.121eyespresentedunilateralinvolvement(55.2%),and92eyespresentedbilateralinvolvement(45.3%)withonsetalternately.22eyesoccurredhypopyon,16eyeswerefoundanteriorvitreouscells,7eyeswerenotedreactivemacularedemaorexudation,29eyespresentedposteriorsynechiaeofiris,and14eyespresentedcataract,9eyespresentedsecondaryglaucoma,2eyespresentedbendcornealdegenerationand1eyespresentedatrophyofeyeball.Atthefinalvisit,uveitiswaswellcontrolledinmostpatients.·CONCLUSION:ASassociatedwithuveitisinChinesepatientsmainlymanifestsasacuteanterioruveitis.AcombinationofcorticosteroidswithothermydriasisagentsiseffectiveformostASassociatedwithuveitispatients.Ingeneral,theprognosisisgoodinthesecases.
简介:Choroidalneovascularization(CNV)isanuncommoncomplicationassociatedwithamacularhole.Inthiscasereportofararecondition,wepresentapathologicmyopiapatientwithaco-existentmacularholeandchoroidalneovascularmembrane.ThepatientwastreatedwithphotodynamictherapyforCNV,andthenvitreoussurgeryfortheretinaldetachmentandmacularhole.Attheendof4yearsfollow-up,hervisualacuitywasimprovedto0.1whilethemacularholeremainedopen.OpticalcoherencetomographyisausefulinspectionmethodofthediagnosisofCNVandmacularhole.
简介:目的探讨前列腺素类药结合玻璃体腔注射雷珠单抗治疗新生血管性青光眼的效果。方法伴发高眼压的新生血管性青光眼患者160例根据随机数字表法分为治疗组80例与对照组80例,两组都给予复合式小梁切除术,对照组选择拉坦前列腺素辅助治疗,治疗组选择拉坦前列腺素联合玻璃体腔注射雷珠单抗辅助治疗。结果治疗后治疗组与对照组的治疗有效率分别为97.5%和88.8%,治疗组的治疗有效率明显高于对照组(P〈0.05)。两组治疗后最佳矫正视力都明显提高,而眼压都明显下降,与治疗前对比差异明显(P〈0.05);同时治疗后治疗组的最佳矫正视力与眼压也都明显好于对照组(P〈0.05)。治疗期间治疗组的眼结膜充血、前房炎症反应、角膜水肿、一过性视觉模糊等并发症发生率都明显低于对照组(P〈0.05)。所有患者治疗后随访调查6个月,治疗组的治疗后3个月与6个月的复发率分别为1.3%和5.0%,而对照组分别为7.5%和13.8%,治疗组治疗后3个月与6个月的复发率明显少于对照组(P〈0.05)。结论前列腺素类药结合玻璃体腔注射雷珠单抗治疗新生血管性青光眼能促进眼压的降低,改善视力水平,安全性好,降低复发,从而有利于近远期疗效的提高。